Clinical Trials Directory

Trials / Unknown

UnknownNCT03692858

IPACK Block in Total Knee Arthroplasty

IPACK Block Efficacy as a Part of Multimodal Analgesia in Total Knee Arthroplasty. A Prospective, Randomized, Controlled, Double Blinded Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Asklepieion Voulas General Hospital · Other Government
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

100 patients ASA I-III, undergoing total knee arthroplasty under spinal anesthesia, will be randomly assigned into one of two groups, namely group A (n=50), where an adductor canal block and an IPACK block will be performed preoperatively and group B (n=50) where an adductor canal block only will be performed preoperatively. All patients will receive a standardized multimodal approach, including pregabalin, paracetamol, and PCA with morphine. NRS scores in static and dynamic conditions during the first 48 hours postoperatively, morphine consumption during the first 24 hours postoperatively will be measured and additionally, patient satisfaction, complications, range of knee motion, moblization, functionality, delirium ocurence will be recorded. Chronic pain will be assessed in 3 and 6 months postoperatively.

Conditions

Interventions

TypeNameDescription
DRUGAdductor Canal Block plus IPACK BlockAdductor Canal Block plus IPACK Block using Ropivacaine
DRUGAdductor Canal BlockAdductor Canal Block using Ropivacaine

Timeline

Start date
2018-10-01
Primary completion
2020-06-01
Completion
2020-07-01
First posted
2018-10-02
Last updated
2019-10-22

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT03692858. Inclusion in this directory is not an endorsement.